Inovio Announces H7N9 DNA Vaccine Protects 100% of Vaccinated Animals
July 08, 2013 at 05:53 AM EDT
Inovio Pharmaceuticals, Inc. (NYSE: INO ) announced today that in a preclinical study of its influenza DNA vaccine against the virulent, newly emergent H7N9 flu virus, 100% of the vaccinated animals were protected against sickness and death when they were challenged with a lethal dose of H7N9 virus. The
